These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin]. Nagai T, Izumi T, Noborio K, Takatoku M, Ohtsuki T, Machii T, Komatsu N, Ozawa K. Rinsho Ketsueki; 2002 Jul; 43(7):583-5. PubMed ID: 12229130 [Abstract] [Full Text] [Related]
5. Brachial plexopathy associated with diffuse edematous scleroderma. Mouthon L, Halimi C, Dussaule Md JC, Cayre-Castel Md M, Guillevin L. Ann Med Interne (Paris); 2000 Jun; 151(4):303-5. PubMed ID: 10922959 [Abstract] [Full Text] [Related]
6. Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: Report of a case. Borges da Costa J, Mayer-da-Silva A, Soares de Almeida LM, Marques Gomes M. Dermatol Online J; 2009 Mar 15; 15(3):11. PubMed ID: 19379655 [Abstract] [Full Text] [Related]
7. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study. Johnston JB, Eisenhauer E, Wainman N, Corbett WE, Zaentz SD, Daeninck PJ. Semin Oncol; 2000 Apr 15; 27(2 Suppl 5):32-6. PubMed ID: 10877049 [Abstract] [Full Text] [Related]
8. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin]. Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D. Srp Arh Celok Lek; 2000 Apr 15; 128(7-8):262-70. PubMed ID: 11089434 [Abstract] [Full Text] [Related]
9. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer. Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R. Semin Oncol; 2000 Apr 15; 27(2 Suppl 5):52-7. PubMed ID: 10877053 [Abstract] [Full Text] [Related]
10. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia. Dillman RO. Expert Rev Anticancer Ther; 2004 Feb 15; 4(1):27-36. PubMed ID: 14748654 [Abstract] [Full Text] [Related]
11. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy]. Rucińska M, Machaczka M, Załuska A, Skotnicki AB. Przegl Lek; 1998 Feb 15; 55(7-8):400-6. PubMed ID: 10021885 [Abstract] [Full Text] [Related]
12. Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine. Juarez M, Marshall R, Denton C, Evely R. Rheumatology (Oxford); 2008 Nov 15; 47(11):1734-5. PubMed ID: 18812428 [No Abstract] [Full Text] [Related]
14. [Immunosuppressive therapy in polymyositis (author's transl)]. Vergara F, Ulloa P, Reginato A, Cartier L. Rev Med Chil; 1978 Nov 14; 106(11):878-83. PubMed ID: 749110 [No Abstract] [Full Text] [Related]
15. Localized subcutaneous Nocardia farcinica abscess in a woman with overlap syndrome between systemic scleroderma and polymyositis. Auzary C, Mouthon L, Soilleux M, Cohen P, Boiron P, Guillevin L. Ann Med Interne (Paris); 1999 Nov 14; 150(7):582-4. PubMed ID: 10637675 [Abstract] [Full Text] [Related]
16. Phase II trials of pentostatin (Nipent) in hairy cell leukemia. Kraut EH. Semin Oncol; 2000 Apr 14; 27(2 Suppl 5):27-31. PubMed ID: 10877048 [Abstract] [Full Text] [Related]